查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771577

美国经肠营养市场规模、份额、趋势分析报告：按产品、流程类型、阶段、适应症、最终用途、销售管道、细分预测，2025-2030 年

U.S. Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage, By Indication, By End use, By Sales Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

预计 2024 年美国经肠营养市场价值将达到 20.6 亿美元，2025 年至 2030 年的复合年增长率将达到 5.7%。

癌症、中风、多发性硬化症、失智症、慢性肝病、慢性阻塞性肺病(COPD) 和糖尿病等慢性疾病的盛行率不断上升，预计将增加对解决经口餵食难题的产品的需求。根据美国疾病管制与预防中心 (CDC) 2024 年 5 月发布的报告，美国约有 3,840 万人患有糖尿病，约占总人口的 11.96%。

阿兹海默症的盛行率不断上升，推动了对经肠营养的需求。晚期患者常面临吞嚥问题，需要营养补充。据美国疾病管制与预防中心称，美国约有690万人患有阿兹海默症。此外，到2022年，它将成为美国成年人第七大死因，也是65岁以上成年人第六大死因。美国老龄人口的不断增长是推动经肠营养需求的另一个重要因素。随着年龄的增长，人们通常会出现生理变化，例如食慾下降、吞嚥困难和消化效率降低，如果管理不当，会导致营养不良。经肠营养为确保老年人，特别是居住在辅助生活或长期照护机构的老年人获得充足的营养摄取提供了实用的解决方案。

看护者和医疗保健提供者越来越意识到老年护理中早期营养干预的重要性，这进一步刺激了经肠营养产品的采用。

早产率的上升是推动口服餵食配方奶粉需求成长的关键因素之一，以满足新生儿的营养需求。根据美国疾病管制与预防中心 (CDC) 2022 年的数据，美国每 10 个新生儿中约有 1 个是早产儿。此外，营养缺乏症和其他营养素缺乏症（包括微量营养素、蛋白质和其他营养素的严重缺乏，尤其是在婴儿和孕妇中）的持续增加，导致对经肠营养奶粉的需求增加。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场展望
  • 技术概述
  • 定价分析
  • 消费行为分析
    • 招募模式
    • 购买行为
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 产业挑战
  • 商业环境分析
    • 波特五力分析
    • PESTLE分析
    • COVID-19的影响

第四章美国经肠营养市场：产品评估与趋势分析

  • 细分仪表板
  • 经肠营养市场：2023 年和 2030 年产品变化分析
    • 标准
    • 疾病

第五章美国经肠营养市场：流量类型估计与趋势分析

  • 细分仪表板
  • 经肠营养市场：2023 年和 2030 年流量类型变化分析
    • 间歇进料流量
    • 常规供应流

第六章：美国经肠营养市场：阶段评估与趋势分析

  • 细分仪表板
  • 经肠营养市场：2023 年和 2030 年阶段变化分析
  • 成人
  • 孩子们

第七章美国经肠营养市场：适应症与趋势分析

  • 细分仪表板
  • 经肠营养市场：2023年及2030年适应症变化分析
  • 阿兹海默症
  • 营养缺乏
    • 癌症护理
    • 糖尿病
    • 慢性肾臟病
    • 罕见疾病
    • 吞嚥问题
    • 疼痛管理
    • 吸收不良/胃肠道疾病/腹泻
    • 其他的

第八章美国经肠营养市场：最终用途估计与趋势分析

  • 细分仪表板
  • 经肠营养市场：2023 年和 2030 年最终用途趋势分析
    • 医院
    • 居家护理

第九章美国经肠营养市场：销售管道评估与趋势分析

  • 细分仪表板
  • 经肠营养市场：2023 年和 2030 年销售管道变化分析
    • 网上销售
    • 零售销售
    • 机构投资人销售

第十章 竞争格局

  • 2024年公司市场占有率分析（%）
  • 公司分类
  • 公司简介/上市公司
    • Ajinomoto Cambrooke
    • Global Health Products, Inc.
    • Kate Farms
    • Abbott
    • Danone SA
    • Kabi AG
    • Nestle
    • Primus Pharmaceuticals, Inc.
    • Mead Johnson &Company, LLC
    • Alcresta Therapeutics
    • Real Food Blends
    • B. Braun SE
Product Code: GVR-4-68040-613-4

Market Size & Trends:

The U.S. enteral feeding formulas market size was estimated at USD 2.06 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obstructive pulmonary disease (COPD), and diabetes, is anticipated to increase the demand for products addressing oral intake challenges. The Centers for Disease Control and Prevention (CDC) reports published in May 2024 states that approximately 38.4 million people in U.S. have diabetes, which is around 11.96% of the overall population.

The growing prevalence of Alzheimer's disease is boosting demand for enteral feeding formulas, as patients in advanced stages often face difficulty in swallowing and require nutritional support. According to the CDC, around 6.9 million people in the U.S. are living with Alzheimer's disease. Furthermore, in 2022, it was the 7th leading cause of death among U.S. adults and the 6th leading cause of death among adults 65 years or older. The rising aging population in the U.S. is another key factor driving the demand for enteral feeding formulas. As individuals age, they often experience physiological changes such as reduced appetite, swallowing difficulties (dysphagia), and decreased digestive efficiency, leading to malnutrition if not properly managed. Enteral feeding provides a practical solution to ensure adequate nutrient intake among elderly individuals, particularly those residing in assisted living or long-term care facilities.

Increased awareness among caregivers and healthcare providers regarding the importance of early nutritional intervention in geriatric care is further fueling the adoption of enteral nutrition products.

Rise in preterm births is one of the significant factors boosting the demand for sip feeds to meet the nutritional requirements of newborns. According to the CDC in 2022, preterm birth affected about 1 of every 10 infants born in the U.S. In addition, the continued rise in nutritional and other deficiencies, including severe deficiency of micronutrients, proteins, and other nutrients, especially in infants and pregnant women, is leading to an increase in the demand for enteral feeding formulas.

U.S. Enteral Feeding Formulas Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. enteral feeding formulas market report based on product, flow type, stage, indication, end use, and sales channel.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Standard Formula
  • Disease-specific Formulas
  • Flow Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Intermittent Feeding Flow
  • Continuous Feeding Flow
  • Stage Outlook (Revenue, USD Million, 2018 - 2030)
  • Adults
  • Pediatrics
  • Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
  • Home Care
  • Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Online Sales
  • Retail Sales
  • Institutional Sales

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Flow Type
    • 1.2.3. Stage
    • 1.2.4. Indication
    • 1.2.5. End Use
    • 1.2.6. Sales Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Technology Overview
  • 3.3. Pricing Analysis
  • 3.4. Consumer Behavior Analysis
    • 3.4.1. Adoption Pattern
    • 3.4.2. Purchasing behaviors
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
      • 3.5.1.1. Rising geriatric population
      • 3.5.1.2. Growing prevalence of chronic diseases
      • 3.5.1.3. Shifting trend toward consumption of disease-specific formulas
      • 3.5.1.4. Growing demand for neonatal and preterm enteral feeding
    • 3.5.2. Market Restraint Analysis
      • 3.5.2.1. Lack of awareness in the medical community
      • 3.5.2.2. Improper categorization of clinical nutrition
    • 3.5.3. Market Opportunity Analysis
    • 3.5.4. Industry Challenges
      • 3.5.4.1. Complications associated with small-bore connectors
      • 3.5.4.2. Risks associated with enteral feeding
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
      • 3.6.1.1. Supplier power
      • 3.6.1.2. Buyer power
      • 3.6.1.3. Substitution threat
      • 3.6.1.4. Threat of new entrant
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic landscape
      • 3.6.2.3. Social landscape
      • 3.6.2.4. Technological landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape
    • 3.6.3. Impact of COVID 19

Chapter 4. U.S. Enteral Feeding Formulas Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Enteral Feeding Formulas Market: Product Movement Analysis, 2023 & 2030 (USD Million)
    • 4.2.1. Standard formula
      • 4.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Disease-specific formula
      • 4.2.2.1. Market Estimates and forecasts, 2018 - 2030(USD Million)

Chapter 5. U.S. Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Enteral Feeding Formulas Market: Flow Type Movement Analysis, 2023 & 2030 (USD Million)
    • 5.2.1. Intermittent Feeding Flow
      • 5.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Continuous Feeding Flow
      • 5.2.2.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Enteral Feeding Formulas Market: Stage Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Adult
    • 6.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pediatric
    • 6.4.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Enteral Feeding Formulas Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Alzheimer's Disease
    • 7.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Nutrition Deficiency
    • 7.4.1. Nutrition Deficiency, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Cancer Care
    • 7.4.3. Cancer Care, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Diabetes
    • 7.4.5. Diabetes, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Chronic Kidney Diseases
    • 7.4.7. Chronic Kidney Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Orphan Diseases
    • 7.4.9. Orphan Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.10. Dysphagia
    • 7.4.11. Dysphagia, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.12. Pain Management
    • 7.4.13. Pain Management, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.14. Malabsorption/GI Disorder/Diarrhea
    • 7.4.15. Malabsorption/Gi Disorder/Diarrhea, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.16. Others
    • 7.4.17. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Enteral Feeding Formulas Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Enteral Feeding Formulas Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
    • 8.2.1. Hospitals
      • 8.2.1.1. Hospitals Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.1.Cardiology
          • 8.2.1.1.1.1. Cardiology Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.2.Neurology
          • 8.2.1.1.2.1. Neurology, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.3.Critical Care (ICU)
          • 8.2.1.1.3.1. Critical Care (ICU) Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.4.Oncology
          • 8.2.1.1.4.1. Oncology Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.5.Others
          • 8.2.1.1.5.1. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. Home Care
      • 8.2.2.1. Home Care Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Enteral Feeding Formulas Market: Sales Channel Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. Enteral Feeding Formulas Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
    • 9.2.1. Online Sales
      • 9.2.1.1. Online Sales Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. Retail Sales
      • 9.2.2.1. Retail Sales Market Revenue Estimates and forecasts, 2018 - 2030
    • 9.2.3. Institutional Sales
      • 9.2.3.1. Institutional Sales Market Revenue Estimates and forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2024 (%)
  • 10.2. Company Categorization
  • 10.3. Company Profiles/Listing
    • 10.3.1. Ajinomoto Cambrooke
      • 10.3.1.1. Overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Product benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Global Health Products, Inc.
      • 10.3.2.1. Overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Kate Farms
      • 10.3.3.1. Overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Abbott
      • 10.3.4.1. Overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Danone S.A
      • 10.3.5.1. Overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Kabi AG
      • 10.3.6.1. Overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Nestle
      • 10.3.7.1. Overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Primus Pharmaceuticals, Inc.
      • 10.3.8.1. Overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Mead Johnson & Company, LLC
      • 10.3.9.1. Overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Alcresta Therapeutics
      • 10.3.10.1. Overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Real Food Blends
      • 10.3.11.1. Overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. B. Braun SE
      • 10.3.12.1. Overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. Enteral feeding formulas market, Product, 2018 - 2030 (USD Million)
  • Table 4. U.S. Enteral feeding formulas market, by Flow Type, 2018 - 2030 (USD Million)
  • Table 5. U.S. Enteral feeding formulas market, by Stage, 2018 - 2030 (USD Million)
  • Table 6. U.S. Enteral feeding formulas market, by Indication, 2018 - 2030 (USD Million)
  • Table 7. U.S. Enteral feeding formulas market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. U.S. Enteral feeding formulas market, by Sales Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 U.S. Enteral feeding formulas market: Products movement analysis
  • Fig. 17 U.S. Enteral feeding formulas market: Products outlook and key takeaways
  • Fig. 18 Standard Formula market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Disease-Specific Formulas market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Enteral feeding formulas market: Flow Type movement analysis
  • Fig. 21 U.S. Enteral feeding formulas market: Flow Type outlook and key takeaways
  • Fig. 22 Intermittent feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Continuous feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Enteral feeding formulas market: Stage movement analysis
  • Fig. 25 U.S. Enteral feeding formulas market: Stage outlook and key takeaways
  • Fig. 26 Adults market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Pediatrics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. Enteral feeding formulas market: Indication movement analysis
  • Fig. 29 U.S. Enteral feeding formulas market: Indication outlook and key takeaways
  • Fig. 30 Alzheimer's market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Nutrition Deficiency market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Cancer Care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Chronic Kidney Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Orphan Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Dysphagia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Pain Management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Malabsorption/GI Disorder/Diarrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Enteral feeding formulas market: End Use movement analysis
  • Fig. 41 U.S. Enteral feeding formulas market: End Use outlook and key takeaways
  • Fig. 42 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Critical Care (ICU) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Home Care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. Enteral feeding formulas market: Sales Channel movement analysis
  • Fig. 49 U.S. Enteral feeding formulas market: Sales Channel outlook and key takeaways
  • Fig. 50 Online sales market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Retail sales market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Institutional sales market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Market Participant Categorization
  • Fig. 54 Strategy mapping
  • Fig. 55 Company market position analysis